An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
D000818:Animals; D001921:Brain / Q000201:enzymology; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology; D003523:Cycloserine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004298:Dopamine / Q000502:physiology; D004357:Drug Synergism; D010134:Fenclonine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology*; D008124:Locomotion / Q000187:drug effects*; D008297:Male; D008715:Methionine / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000502:physiology; D011748:Pyrogallol / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000502:physiology
D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D011748:Pyrogallol; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D003523:Cycloserine; D008715:Methionine; D002262:Carboxy-Lyases; D006220:Haloperidol; D010134:Fenclonine; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine